A point-of-care device for HbA1C has been launched by Quotient Diagnostics.
Shown at the IBMS Conference, the Quo-Test A1C analyser has been developed to improve diabetes management, providing on-the-spot results.
Quo-Test is a laboratory instrument designed for use in primary-care environments.
The A1C test requires minimal handling and automatic calibration ensures maximum precision and accuracy with full data connectivity and options to print results on a sticky label.
With a small footprint and low weight, it can be easily transported to satellite facilities, outreach clinics or other community settings.
Quo-Test A1C is traceable to the IFCC reference method and has been certified by the National Glycohaemoglobin Standardization Programme (NGSP).
